United States · FDA National Drug Code directory
CONEXXENCE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-668_f778a079-d075-4205-bc94-8ec67e27c95e
- Product NDC
- 65219-668
- Form
- INJECTION
- Composition / generic term
- Denosumab
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250630
- Source listing expiry
- 20261231
Source-listed ingredients
- DENOSUMAB — 60 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, PLASTIC in 1 CARTON (65219-668-01) / 1 mL in 1 SYRINGE, PLASTIC · 65219-668-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →